About this trial

Patients with combat-related amputations frequently experience chronic neuroma pain that may interfere with rehabilitation, prosthesis use, mobility, sleep, and quality of life. Current treatment approaches often provide only temporary pain relief.

Platelet-rich plasma (PRP) has emerged as a potential regenerative treatment option because of its possible effects on tissue healing, neuroinflammation, and peripheral nerve irritation. However, its role in the treatment of chronic neuroma pain after amputation remains unclear.

This prospective multicenter controlled study aims to compare ultrasound-guided PRP injection around the neuroma with ultrasound-guided local anesthetic injection in patients with chronic neuroma pain after combat-related amputation.

Participants will undergo one of the two injection treatments and will be followed over time to evaluate changes in pain intensity, neuropathic pain symptoms, phantom limb pain, prosthesis tolerance, and functional outcomes.

The goal of the study is to evaluate the safety, feasibility, and potential clinical effectiveness of PRP injection for chronic neuroma pain following combat-related amputation.

Eligibility criteria

Qualifiers

Age ≥18 years

Combat-related limb amputation

Chronic neuroma pain lasting ≥3 months

Ultrasound-confirmed painful neuroma

Disqualifiers

Active infection at or near the injection site

Open wound preventing safe injection

Previous PRP injection for neuroma pain within 6 months

Previous neuroma surgery within 3 months

Trial design

Treatments tested in this trial

  • Platelet-Rich Plasma (PRP) Injections
  • Local Anesthetic Injection

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

2
Feofaniya Clinical Hospital03143, Kyiv Ukraine
Vinnitsya university hospital21000, Vinnytsia Ukraine

Sponsors and collaborators

Ukrainian Society of Regional Anesthesia and Pain Therapy

Lead sponsor